These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32718075)

  • 21. Fluorine-18 Labeled Fluorofuranylnorprogesterone ([
    Basuli F; Zhang X; Blackman B; White ME; Jagoda EM; Choyke PL; Swenson RE
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31261651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET.
    Beattie BJ; Smith-Jones PM; Jhanwar YS; Schöder H; Schmidtlein CR; Morris MJ; Zanzonico P; Squire O; Meirelles GS; Finn R; Namavari M; Cai S; Scher HI; Larson SM; Humm JL
    J Nucl Med; 2010 Feb; 51(2):183-92. PubMed ID: 20080885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.
    Dehdashti F; Laforest R; Gao F; Aft RL; Dence CS; Zhou D; Shoghi KI; Siegel BA; Katzenellenbogen JA; Welch MJ
    J Nucl Med; 2012 Mar; 53(3):363-70. PubMed ID: 22331216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine Uptake of Estrogen and Progestogen-Based Radiotracers in Rhesus Macaques with Endometriosis.
    Wilson RC; Link JM; Lee YZ; Oldan JD; Young SL; Slayden OD
    Mol Imaging Biol; 2024 Apr; 26(2):334-343. PubMed ID: 38133866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
    Larson SM; Morris M; Gunther I; Beattie B; Humm JL; Akhurst TA; Finn RD; Erdi Y; Pentlow K; Dyke J; Squire O; Bornmann W; McCarthy T; Welch M; Scher H
    J Nucl Med; 2004 Mar; 45(3):366-73. PubMed ID: 15001675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-
    Ulaner GA; Mankoff DA; Clark AS; Fowler AM; Linden HM; Peterson LM; Dehdashti F; Kurland BF; Mortimer J; Mouabbi J; Moon DH; de Vries EGE
    J Nucl Med; 2023 Mar; 64(3):351-354. PubMed ID: 36863779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report on the PET/CT Image-Based Radiation Dosimetry of [
    McCall KC; Liu M; Cheng SC; Abbott A; Dubey S; Young D; Johnston M; Van den Abbeele AD; Overmoyer B; Jacene H
    J Nucl Med Technol; 2023 Sep; 51(3):204-210. PubMed ID: 37316304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast Cancer.
    Ulaner GA; Fowler AM; Clark AS; Linden H
    PET Clin; 2023 Oct; 18(4):531-542. PubMed ID: 37270377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron tomographic assessment of androgen receptors in prostatic carcinoma.
    Dehdashti F; Picus J; Michalski JM; Dence CS; Siegel BA; Katzenellenbogen JA; Welch MJ
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):344-50. PubMed ID: 15726353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [
    Orevi M; Shamni O; Zalcman N; Chicheportiche A; Mordechai A; Moscovici S; Shoshan Y; Shahar T; Charbit H; Gutreiman M; Paldor I; Mishani E; Lossos A; Lavon I
    Neurooncol Adv; 2021; 3(1):vdab019. PubMed ID: 33738450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual and quantitative evaluation of [
    Mammatas LH; Venema CM; Schröder CP; de Vet HCW; van Kruchten M; Glaudemans AWJM; Yaqub MM; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Hoekstra OS; Hospers GAP; der Houven van Oordt CWM
    EJNMMI Res; 2020 Apr; 10(1):40. PubMed ID: 32307594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using
    Jager A; de Vries EGE; der Houven van Oordt CWM; Neven P; Venema CM; Glaudemans AWJM; Wang Y; Bagley RG; Conlan MG; Aftimos P
    Breast Cancer Res; 2020 Sep; 22(1):97. PubMed ID: 32912274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer.
    Ulaner GA
    Semin Nucl Med; 2022 Sep; 52(5):574-583. PubMed ID: 35379454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET Imaging of Estrogen Receptors Using
    Kumar M; Salem K; Jeffery JJ; Fowler AM
    Methods Mol Biol; 2022; 2418():129-151. PubMed ID: 35119664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fully automated radiosynthesis and quality control of estrogen receptor targeting radiopharmaceutical 16α-[
    Wang M; Glick-Wilson BE; Zheng QH
    Appl Radiat Isot; 2020 Jun; 160():109109. PubMed ID: 32174461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer.
    Dehdashti F; Mortimer JE; Trinkaus K; Naughton MJ; Ellis M; Katzenellenbogen JA; Welch MJ; Siegel BA
    Breast Cancer Res Treat; 2009 Feb; 113(3):509-17. PubMed ID: 18327670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uterine uptake of estrogen and progestogen-based radiotracers in rhesus macaques with endometriosis.
    Wilson RC; Link JM; Lee YZ; Oldan JD; Young SL; Slayden OD
    Res Sq; 2023 Sep; ():. PubMed ID: 37720028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
    Paquette M; Phoenix S; Ouellet R; Langlois R; van Lier JE; Turcotte EE; Bénard F; Lecomte R
    Mol Imaging Biol; 2013 Oct; 15(5):625-32. PubMed ID: 23619898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT.
    van Kruchten M; de Vries EF; Arts HJ; Jager NM; Bongaerts AH; Glaudemans AW; Hollema H; de Vries EG; Hospers GA; Reyners AK
    J Nucl Med; 2015 Jan; 56(1):50-5. PubMed ID: 25476534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.